Suzanne M. Vautrinot - 14 Aug 2025 Form 4 Insider Report for ECOLAB INC. (ECL)

Role
Director
Signature
/s/ Corinne Lawson, as Attorney-in-Fact for Suzanne M. Vautrinot
Issuer symbol
ECL
Transactions as of
14 Aug 2025
Net transactions value
-$383,278
Form type
4
Filing time
19 Aug 2025, 16:32:57 UTC
Previous filing
02 Jul 2025
Next filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vautrinot Suzanne M Director C/O ECOLAB INC., 1 ECOLAB PLACE, ST. PAUL /s/ Corinne Lawson, as Attorney-in-Fact for Suzanne M. Vautrinot 19 Aug 2025 0001589791

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ECL Common Stock Options Exercise $264,672 +2,300 +21% $115.08 13,499 14 Aug 2025 Direct
transaction ECL Common Stock Tax liability $264,549 -946 -7% $279.65 12,553 14 Aug 2025 Direct F1
transaction ECL Common Stock Sale $383,401 -1,354 -11% $283.16 11,199 19 Aug 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ECL Non-Employee Stock Option (Right to Buy) Options Exercise $0 -2,300 -100% $0.000000 0 14 Aug 2025 Common Stock 2,300 $115.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the reporting person's payment of the exercise price for a stock option issued in accordance with Rule 16b-3 by delivering or withholding shares of Ecolab common stock.
F2 This transaction was executed in multiple trades at prices ranging from $283.146 to $283.165, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date.